Novo Nordisk has announced that it's cutting the price of pre-filled insulin pens and vials by up to 75 percent for people living with diabetes starting in January 2024.
"We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes," said Steve Albers, senior vice president of market access and public affairs at Novo Nordisk, Inc. "Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously."
Earlier this month, rival drugmaker Eli Lilly announced plans to reduce insulin prices by 70 percent and cap patient out-of-pocket costs for insulin at $35 per month.
The Biden administration has put public pressure on drugmakers to make medically necessary insulins more affordable. Novo Nordisk notably did not put a cap on out-of-pocket expenses.
Novo Nordisk will lower the price for four different brands, including NovoLog® and NovoLog® Mix 70/30 by 75 percent and Novolin® and Levemir® by 65 percent.
Ford Motor Co. is resuming construction on a Michigan electric vehicle battery plant that the company postponed two months ago during a strike by the United Auto Workers union.
The marketing slogan for Stanley Tumbler flask products is built for life and it looks like one video proves that to be true after a woman showed her burned-out car on TikTok along with her Tumbler cup, which was left undamaged.
Nvidia's stock closed at an all-time high Monday at above $504 a share, ahead of the company's latest quarterly earnings report which is due out later Tuesday.
The CEOs of three popular tech companies have been subpoenaed by the Senate Judiciary Committee, which ordered the heads of Discord, Snap and X to testify at a hearing on protecting children online.
